LEADER 01811oam  2200445Ia 450 
001 9910698829703321
005 20090527134310.0
035   $a(CKB)5470000002397571
035   $a(OCoLC)352887266
035   $a(EXLCZ)995470000002397571
100   $a20090527d2002      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $erecommendations for deferral of donors and quarantine and retrieval of blood and blood products in recent recipients of smallpox vaccine (vaccinia virus) and certain contacts of smallpox vaccine recipients
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research,$d[2002]
215   $ai, 9 pages $cdigital, PDF file
300   $aTitle from PDF title page (viewed on May 27, 2009).
300   $a"Final guidance".
300   $a"December 2002".
320   $aIncludes bibliographical references (page 8).
517   $aGuidance for industry 
606   $aQuarantine$xGovernment policy$zUnited States
606   $aBlood products$xGovernment policy$zUnited States
606   $aBlood donors$xGovernment policy$zUnited States
606   $aSmallpox$xPrevention$xGovernment policy$zUnited States
615  0$aQuarantine$xGovernment policy
615  0$aBlood products$xGovernment policy
615  0$aBlood donors$xGovernment policy
615  0$aSmallpox$xPrevention$xGovernment policy
712 02$aCenter for Biologics Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
801  2$bGPO
906   $aBOOK
912   $a9910698829703321
996   $aGuidance for industry$93434577
997   $aUNINA